Stocks and Investing
Stocks and Investing
Fri, October 21, 2022
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
Jailendra Singh Maintained (TDOC) at Hold with Decreased Target to $29 on, Oct 21st, 2022
Jailendra Singh of Truist Securities, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Decreased Target from $35 to $29 on, Oct 21st, 2022.
Jailendra has made no other calls on TDOC in the last 4 months.
There are 14 other peers that have a rating on TDOC. Out of the 14 peers that are also analyzing TDOC, 9 agree with Jailendra's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $33 on, Tuesday, October 11th, 2022
- George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $31 on, Tuesday, September 27th, 2022
- Scott Schoenhaus of "Keybanc" Initiated at Hold on, Friday, September 16th, 2022
- Ravi Misra of "Berenberg" Downgraded from Strong Buy to Hold and Decreased Target to $35 on, Tuesday, August 2nd, 2022
- Charles Rhyee of "Cowen & Co." Downgraded from Buy to Hold and Decreased Target to $34 on, Tuesday, August 2nd, 2022
- Cindy Motz of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $36 on, Thursday, July 28th, 2022
- Ryan MacDonald of "Needham" Downgraded from Strong Buy to Hold on, Thursday, July 28th, 2022
- Stephanie Davis Demko of "SVB Leerink" Maintained at Hold with Decreased Target to $34 on, Thursday, July 28th, 2022
- David Grossman of "Stifel" Maintained at Hold with Decreased Target to $36 on, Wednesday, June 29th, 2022
These are the ratings of the 5 analyists that currently disagree with Jailendra
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Wednesday, September 28th, 2022
- Sandy Draper of "Guggenheim" Downgraded from Hold to Strong Sell and Held Target at $25 on, Wednesday, August 17th, 2022
- Robert Simmons of "DA Davidson" Initiated at Strong Buy and Held Target at $45 on, Friday, August 12th, 2022
- Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $40 on, Thursday, July 28th, 2022
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $55 on, Thursday, July 28th, 2022
Contributing Sources